Dr. Anna K. Junk, MD

Dr. Junk practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Junk's NPI, 1578572244, was assigned on August 5, 2006. Dr. Junk graduated from Ludwig Maximilian University of Munich Faculty of Medicine in 1994. Dr. Junk holds Florida license ME96479.

Dr. Junk's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Junk's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Junk to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Junk practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Junk's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Junk is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Junk's licenses on file in 3 states: Florida, New York and Pennsylvania.

Dmand AI lists cataract, cataract surgery with lens implant, dry eye, glaucoma, glaucoma surgery, secondary membranaous cataract surgery and vision problems among the conditions Dr. Junk treats.

CMS data shows 162 Medicare services from Dr. Junk across 3 procedure codes in 2024, for 65 Medicare patients. Medicare paid $7,509 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 65 Medicare patients who saw Dr. Junk in 2024. The largest group is 75 to 84, with 24 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Junk's median patient age at 75, with 53% women.

In 2024, Dr. Junk wrote 767 Medicare Part D claims for 114 patients. 63% of them were for generic drugs. CMS names the drug for 706 of them, across 13 drugs with 11 or more claims each, at $43,728 in total drug cost. In 2023, CMS named 856 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Junk for performance year 2024, reported as part of a group. Dr. Junk accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 34 papers to Dr. Junk, published from 2002 to 2025. 2018 was the busiest year, with 3. The most frequent topics are Glaucoma, Glaucoma, Open-Angle and Intraocular Pressure. Dr. Junk has published most often in J Glaucoma. Dr. Junk's most frequent co-authors are Sanjoy Bhattacharya, MD, Teresa C. Chen, MD and Anat Galor, MD.

CMS Open Payments shows 30 general payments to Dr. Junk from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 72% of the total. Alcon Laboratories Inc paid the most, $969.

Dmand AI lists 1 award for Dr. Junk.

Dr. Junk graduated from Ludwig Maximilian University of Munich Faculty of Medicine in 1994. Dr. Junk is a member of AAO, American Glaucoma Society and ASCRS.

Dr. Junk is in network with 12 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.